COPD8USA: A Multi-Disciplinary Clinical and Scientific Conference

描述（由申请人提供）：慢性阻塞性肺疾病（COPD）是一种流行；慢性阻塞性肺病是一种逐渐使人衰弱的健康状况，在美国影响超过1200万确诊患者和估计还有1200多万未确诊患者。慢性阻塞性肺病每年造成约14万人死亡，成本超过500亿美元。与其他主要死亡原因不同，慢性阻塞性肺病持续上升，2008年，它成为美国第三大死亡原因。慢性阻塞性肺病患者可能多年未被发现，即使诊断正确，患者也经常接受不一致的护理，不遵循基于证据的做法，考虑到多种复杂的合并症，或在团队方法中实践以患者为中心的原则。公共和私人研究投资已经取得了巨大的进步，然而研究表明，许多患者并没有从这些进步中受益，研究差距仍然很大。临床护理团队往往缺乏对新疗法的充分培训，并且各自为战，妨碍了适当的护理协调，并造成了从实验室到病床的更大障碍。国家心脏、肺和血液研究所（NHLBI）致力于COPD基础研究的需求，并与临床和患者社区建立联系，以确保改善公共卫生状况。NHLBI对慢性阻塞性肺病遗传流行病学项目、Spiromics和NETT的资助因其对慢性阻塞性肺病的投资而受到称赞：为了满足教育和研究论坛的需求，以促进公共和私人的多学科交流，专注于COPD， COPD基金会与国际专家Robert Stockley和Sue Hill合作，使成功的欧洲COPD会议系列适应美国的具体需求。COPD8USA是美国系列的第二个会议，将于2013年6月13日至15日在伊利诺伊州芝加哥与COPD会前再入院峰会和COPD社区教育研讨会一起召开。内布拉斯加大学医学中心继续教育中心（UNMC-CCE）将作为COPD8USA的认证提供者。COPD8USA的总体目标是刺激政府、临床、研究和患者社区创建一个协调和全面的方法，以改善研究、临床护理、护理提供协调和其他公共卫生干预措施的知识和实施，这对逆转COPD日益增长的负担至关重要。COPD8USA的参与者和教师代表了整个临床护理团队、学术研究人员、医院管理人员和护理协调员、政府和私人政策制定者以及受疾病影响的患者和护理人员。COPD8USA提供了一个独特的论坛，促进COPD专家和与会者（包括年轻研究人员）之间的学习和互动。

DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a prevalent; progressively debilitating health condition that affects over 12 million diagnosed and an estimated 12 million more undiagnosed individuals in the U.S. COPD is responsible for approximately 140,000 deaths and costs upwards of 50 billion annually. Unlike other leading causes of death, COPD continues to rise and in 2008, it became the 3rd leading cause of death in the US. Individuals with COPD may spend years undetected and even when diagnosed properly, individuals often receive inconsistent care that does not follow evidence based practices, account for the multiple complex comorbid conditions or practice patient centered principles in a team approach. Public and private research investment has yielded great advances, yet studies show many patients do not benefits from these advances and large research gaps remain. The clinical care team often lacks sufficient training on new therapies and work in silos, preventing proper care coordination and causing even greater barriers in translating from the bench to bedside. The National Heart, Lung and Blood Institute (NHLBI) have shown dedication to the need for basic research in COPD, and to making the connections to the clinical and patient communities to ensure improvements to public health status. The NHLBI's funding for the Genetic Epidemiology of COPD project, Spiromics and NETT are complimented by its investment in the COPD: Learn More Breathe Better Campaign and its commitment to inter-agency partnerships to advance the epidemiological study of COPD in the U.S. To meet the need for a education and research forum to advance public and private, multi-disciplinary communication solely focused on COPD, the COPD Foundation partnered with international experts Robert Stockley and Sue Hill to adapt the successful European COPD Conferences Series to US specific needs. COPD8USA is the second in the US series and will be convened alongside the Readmissions in COPD Pre-Conference Summit and the COPD Community Education Workshop from June 13-15, 2013 in Chicago, IL. The University of Nebraska Medical Center, Center for Continuing Education (UNMC-CCE) will serve as the accredited provider for COPD8USA. The overall objective of COPD8USA is to stimulate the government, clinical, research and patient communities to create a coordinated and comprehensive approach for improvements in the knowledge and implementation of research, clinical care, care delivery coordination and other public health interventions critical to reversig the growing burden of COPD. COPD8USA participants and faculty represent the entire spectrum of clinical care teams, academic researchers, hospital administrators and care coordinators, government and private policy makers and patients and caregivers that are affected by the disease. COPD8USA offers a unique forum to foster learning and interactions between COPD experts and conference attendees, including young investigators.